These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4425844)

  • 41. Adult-onset minimal change nephrotic syndrome: a long-term follow-up.
    Nolasco F; Cameron JS; Heywood EF; Hicks J; Ogg C; Williams DG
    Kidney Int; 1986 Jun; 29(6):1215-23. PubMed ID: 3747335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Results of cyclophosphamide treatment of primary nephrotic syndrome in children].
    Starkiewiczowa J; Fydryk J; Lupa B
    Pediatr Pol; 1975 Jan; 50(1):31-6. PubMed ID: 1110844
    [No Abstract]   [Full Text] [Related]  

  • 44. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
    Bailey RR
    N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy.
    Garin EH; Pryor ND; Fennell RS; Richard GA
    J Pediatr; 1978 Feb; 92(2):304-8. PubMed ID: 621614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunity and immunosuppression in childhood idiopathic nephrotic syndrome].
    Frange P; Frey MA; Deschênes G
    Arch Pediatr; 2005 Mar; 12(3):305-15. PubMed ID: 15734130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nephrotic syndrome: from toddlers to twenties.
    Lewis MA; Baildom EM; Davis N; Houston IB; Postlethwaite RJ
    Lancet; 1989 Feb; 1(8632):255-9. PubMed ID: 2563420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management Of Childhood Steroid Dependent Nephrotic Syndrome With Cyclophosphamide - An Experience At Ayub Teaching Hospital, Abbottabad.
    Hussain Shah SS; Aalia B; Raza A; Najeeb S; Rehman AU
    J Ayub Med Coll Abbottabad; 2021; 33(2):213-216. PubMed ID: 34137531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-corticosteroid treatment for nephrotic syndrome in children.
    Durkan A; Hodson E; Willis N; Craig J
    Cochrane Database Syst Rev; 2001; (4):CD002290. PubMed ID: 11687155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of nephrotic syndrome in children (author's transl)].
    Schärer K
    Monatsschr Kinderheilkd; 1980 Nov; 128(11):685-8. PubMed ID: 6110172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
    Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclophosphamide in minimal-change nephrotic syndrome.
    Uldall PR; Feest TG; Morley AR; Tomlinson BE; Kerr DN
    Lancet; 1972 Sep; 2(7776):537-8. PubMed ID: 4115589
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hazard-adapted therapy of acquired idiopathic nephrotic syndromes in children].
    Olbing H
    Dtsch Med Wochenschr; 1973 May; 98(21):1079-85. PubMed ID: 4196141
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
    Skrzypczyk P; Panczyk-Tomaszewska M; Roszkowska-Blaim M; Wawer Z; Bienias B; Zajgzkowska M; Kilis-Pstrusinska K; Jakubowska A; Szczepaniak M; Pawlak-Bratkowska M; Tkaczyk M
    Clin Nephrol; 2014 Mar; 81(3):166-73. PubMed ID: 24361057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclophosphamide in the treatment of childhood nephrotic syndrome.
    Wiggelinkhuizen J; McDonald R; Kaschula RO
    S Afr Med J; 1972 Sep; 46(39):1417-23. PubMed ID: 4642675
    [No Abstract]   [Full Text] [Related]  

  • 58. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.
    Chiu J; McLaine PN; Drummond KN
    J Pediatr; 1973 Apr; 82(4):607-13. PubMed ID: 4698337
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.